Constraints on the genetic and antigenic variability of measles virus

Viruses

Volumn 8, Issue 4, 2016, Pages

  Beaty, Shannon M ^a   Lee, Benhur ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Amino acid substitution; Antigenic drift; Genetic variation; Genomic stability; Genotype; Measles; Mutation rate; Paramyxovirinae; Viral envelope proteins

Indexed keywords

BETA INTERFERON; CD150 ANTIGEN; GREEN FLUORESCENT PROTEIN; LYMPHOCYTE ANTIGEN; MEMBRANE COFACTOR PROTEIN; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN; UNTRANSLATED REGION; VIRAL PROTEIN;

ANTIGENICITY; ENCEPHALITIS; ENTEROVIRUS 71; FOOT DISEASE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC STABILITY; GENETIC VARIABILITY; GENOME; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HENIPAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA A VIRUS; MEASLES; MEASLES VIRUS; MORBILLIVIRUS; MOUTH DISEASE; MUMPS VIRUS; MUTAGENESIS; MUTATION RATE; NONHUMAN; OPEN READING FRAME; PARAMYXOVIRINAE; RESPIROVIRUS; REVIEW; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION; VIRULENCE; VIRUS GENOME; VIRUS MENINGITIS; VIRUS REPLICATION; ADAPTATION; ANIMAL; ANTIGENIC VARIATION; CLASSIFICATION; GENETIC VARIATION; GENETICS; GENOMIC INSTABILITY; HUMAN; IMMUNOLOGY; MUTATION; UNTRANSLATED REGION; VIROLOGY;

ADAPTATION, BIOLOGICAL; ANIMALS; ANTIGENIC VARIATION; GENETIC VARIATION; GENOMIC INSTABILITY; GENOTYPE; HUMANS; MEASLES; MEASLES VIRUS; MUTATION; OPEN READING FRAMES; SEROGROUP; UNTRANSLATED REGIONS; VIRAL PROTEINS;

EID: 84964307422     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8040109     Document Type: Review

References (167)

1. Bellini, W.J., Englund, G., Rozenblatt, S., Arnheiter, H., Richardson, C.D. Measles virus P gene codes for two proteins. J. Virol. 1985, 53, 908-919. [PubMed]
2. Cattaneo, R., Kaelin, K., Baczko, K., Billeter, M.A. Measles virus editing provides an additional cysteine-rich protein. Cell 1989, 56, 759-764. [CrossRef]
3. WHO Global Surveillance. Weekly Epidemiological Record Relevé Épidémiologique Hebdomadaire; World Health Organization: Geneva, Switzerland, 2012; Volume 204, pp. 73-80.
4. Rota, P.A., Brown, K., Mankertz, A., Santibanez, S., Shulga, S., Muller, C.P., Hübschen, J.M., Siqueira, M., Beirnes, J., Ahmed, H., et al. Global Distribution of Measles Genotypes and Measles Molecular Epidemiology. J. Infect. Dis. 2011, 204, S514-S523. [CrossRef] [PubMed]
5. Rota, P.A., Bellini, W.J. Update on the global distribution of genotypes of wild type measles viruses. J. Infect. Dis. 2003, 187 (Suppl. S1), S270-S276. [CrossRef] [PubMed]
6. World Health Organization. Immunization, Vaccines and Biologicals—Measles Surveillance Data. Regional Summary of Reported Measles Cases. Available online: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance:type/active/measles_monthlydata/en/index1.html (accessed on 30 March 2016).
7. Tamin, A., Rota, P.A., Wang, Z.D., Heath, J.L., Anderson, L.J., Bellini, W.J. Antigenic analysis of current wild type and vaccine strains of measles virus. J. Infect. Dis. 1994, 170, 795-801. [CrossRef] [PubMed]
8. Santibanez, S., Niewiesk, S., Heider, A., Schneider-Schaulies, J., Berbers, G.A.M., Zimmermann, A., Halenius, A.; Wolbert, A., Deitemeier, I., Tischer, A., et al. Probing neutralizing-antibody responses against emerging measles viruses (MVs): Immune selection of MV by H protein-specific antibodies? J. Gen. Virol. 2005, 86, 365-374. [CrossRef] [PubMed]
9. Kühne, M., Brown, D.W.G., Jin, L. Genetic variability of measles virus in acute and persistent infections. Infect. Genet. Evol. 2006, 6, 269-276. [CrossRef] [PubMed]
10. Riddell, M.A., Rota, J.S., Rota, P.A. Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras. Virol. J. 2005, 2. [CrossRef] [PubMed]
11. Schneider-Schaulies, J., Niewiesk, S., Schneider-Schaulies, S., Ter Meulen, V. Measles virus in the CNS: The role of viral and host factors for the establishment and maintenance of a persistent infection. J. Neurovirol. 1999, 5, 613-622. [CrossRef] [PubMed]
12. Bellini, W.J., Rota, J.S., Lowe, L.E., Katz, R.S., Dyken, P.R., Zaki, S.R., Shieh, W.-J., Rota, P.A. Subacute sclerosing panencephalitis: More cases of this fatal disease are prevented by measles immunization than was previously recognized. J. Infect. Dis. 2005, 192, 1686-1693. [CrossRef] [PubMed]
13. Bitnun, A., Shannon, P., Durward, A., Rota, P.A., Bellini, W.J., Graham, C., Wang, E., Ford-Jones, E.L., Cox, P., Becker, L., et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin. Infect. Dis. 1999, 29, 855-861. [CrossRef] [PubMed]
14. Hardie, D.R., Albertyn, C., Heckmann, J.M., Smuts, H.E.M. Molecular characterisation of virus in the brains of patients with measles inclusion body encephalitis (MIBE). Virol. J. 2013, 10. [CrossRef] [PubMed]
15. Ivancic-Jelecki, J., Baricevic, M., Santak, M., Harcet, M., Tešovíc, G., Marusic Della Marina, B., Forcic, D. The first genetic characterization of a D4 measles virus strain derived from a patient with subacute sclerosing panencephalitis. Infect. Genet. Evol. 2013, 17, 71-78. [PubMed]
16. Jiang, D.-P., Ide, Y.-H., Nagano-Fujii, M., Shoji, I., Hotta, H. Single-point mutations of the M protein of a measles virus variant obtained from a patient with subacute sclerosing panencephalitis critically affect solubility and subcellular localization of the M protein and cell-free virus production. Microbes Infect. 2009, 11, 467-475. [CrossRef] [PubMed]
17. Hotta, H., Nihei, K., Abe, Y., Kato, S., Jiang, D.-P., Nagano-Fujii, M., Sada, K. Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE. Microbiol. Immunol. 2006, 50, 525-534. [CrossRef] [PubMed]
18. Miki, K., Komase, K., Mgone, C.S., Kawanishi, R., Iijima, M., Mgone, J.M., Asuo, P.G., Alpers, M.P., Takasu, T., Mizutani, T. Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea. J. Med. Virol. 2002, 68, 105-112. [CrossRef] [PubMed]
19. Woelk, C.H., Pybus, O.G., Jin, L., Brown, D.W.G., Holmes, E.C. Increased positive selection pressure in persistent (SSPE) versus acute measles virus infections. J. Gen. Virol. 2002, 83, 1419-1430. [CrossRef] [PubMed]
20. Jin, L., Beard, S., Hunjan, R., Brown, D.W., Miller, E. Characterization of measles virus strains causing SSPE: A study of 11 cases. J. Neurovirol. 2002, 8, 335-344. [PubMed]
21. Schönberger, K., Ludwig, M.S., Wildner, M., Weissbrich, B. Epidemiology of Subacute Sclerosing Panencephalitis (SSPE) in Germany from 2003 to 2009: A Risk Estimation. PLoS ONE 2013, 8, e68909. [CrossRef] [PubMed]
22. Klingele, M., Hartter, H.K., Adu, F., Ammerlaan, W., Ikusika, W., Muller, C.P. Resistance of recent measles virus wild-type isolates to antibody-medicated neutralization by vaccinees with antibody. J. Med. Virol. 2000, 62, 91-98. [CrossRef]
23. Perry, R.T., Gacic-Dobo, M., Dabbagh, A., Mulders, M.N., Strebel, P.M., Okwo-Bele, J.-M., Rota, P.A., Goodson, J.L. Global control and regional elimination of measles, 2000-2012. MMWRMorb. Mortal. Wkly. Rep. 2014, 63, 103-107. [PubMed]
24. Muscat, M., Bang, H., Wohlfahrt, J., Glismann, S., Mølbak, K. Measles in Europe: An epidemiologicalassessment. Lancet 2009, 373, 383-389. [CrossRef]
25. Bouche, F.B., Ertl, O.T., Muller, C.P. Neutralizing B cell response in measles. Viral Immunol. 2002, 15, 451-471. [CrossRef] [PubMed]
26. Ertl, O.T., Wenz, D.C., Bouche, F.B., Berbers, G.A.M., Muller, C.P. Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response. Arch. Virol. 2003, 148, 2195-2206. [CrossRef] [PubMed]
27. Fournier, P., Brons, N.H.C., Berbers, G.A.M., Wiesmüller, K.H., Fleckenstein, B.T., Schneider, F., Jung, G., Muller, C.P. Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J. Gen. Virol. 1997, 78, 1295-1302. [CrossRef] [PubMed]
28. Ziegler, D., Fournier, P., Berbers, G.A., Steuer, H., Wiesmüller, K.H., Fleckenstein, B., Schneider, F., Jung, G., King, C.C., Muller, C.P. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. J. Gen. Virol. 1996, 77, 2479-2489. [CrossRef] [PubMed]
29. Liebert, U.G., Flanagan, S.G., Löffler, S., Baczko, K., ter Meulen, V., Rima, B.K. Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J. Virol. 1994, 68, 1486-1493. [PubMed]
30. Hu, A., Sheshberadaran, H., Norrby, E., Kövamees, J. Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology 1993, 192, 351-354. [CrossRef] [PubMed]
31. Carter, M. J.; Willcocks, M.M., Löffler, S., ter Meulen, V. Relationships between Monocional Antibody-binding Sites on the Measles Virus Haemagglutinin. J.Gen. Virol. 1982, 63, 113-120. [CrossRef] [PubMed]
32. De Swart, R.L., Yüksel, S., Osterhaus, A.D.M.E. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J. Virol. 2005, 79, 11547-11551. [CrossRef] [PubMed]
33. Tahara, M., Ito, Y., Brindley, M.A., Ma, X., He, J., Xu, S., Fukuhara, H., Sakai, K., Komase, K., Rota, P.A., et al. Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein. J. Virol. 2013, 87, 666-675. [CrossRef] [PubMed]
34. Tahara, M., Ohno, S., Sakai, K., Ito, Y., Fukuhara, H., Komase, K., Brindley, M.A., Rota, P.A., Plemper, R.K., Maenaka, K., et al. The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope. J. Virol. 2013, 87, 3583-3586. [CrossRef] [PubMed]
35. Lech, P.J., Tobin, G.J., Bushnell, R., Gutschenritter, E., Pham, L.D., Nace, R., Verhoeyen, E., Cosset, F.L., Muller, C.P., Russell, S.J., et al. Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies. PLoS ONE 2013, 8, e52306. [CrossRef] [PubMed]
36. Fulton, B.O., Sachs, D., Beaty, S. M.; Won, S.T., Lee, B., Palese, P., Heaton, N.S. Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins. Cell Rep. 2015, 11, 1331-1338. [CrossRef] [PubMed]
37. Borges, M.B., Caride, E., Jabor, A.V., Malachias, J.M.N., Freire, M.S., Homma, A., Galler, R. Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures. Virus Genes 2008, 36, 35-44. [CrossRef] [PubMed]
38. Baricevíc, M., Forcic, D., Gulija, T.K., Jug, R., Mazuran, R. Determination of the coding and non-coding nucleotide sequences of genuine Edmonston-Zagreb master seed and current working seed lot. Vaccine 2005, 23, 1072-1078. [CrossRef] [PubMed]
39. Rima, B.K., Earle, J.A., Yeo, R.P., Herlihy, L., Baczko, K., ter Meulen, V., Carabaña, J., Caballero, M., Celma, M.L., Fernandez-Muñoz, R. Temporal and geographical distribution of measles virus genotypes. J. Gen. Virol. 1995, 76 Pt 5, 1173-1180. [CrossRef] [PubMed]
40. Rota, P., Featherstone, D., Bellini, W. Molecular epidemiology of measles virus. Curr. Top. Microbiol. Immunol. 2009, 330, 129-150.
41. Rima, B.K., Mcferran, N.V. Dinucleotide and stop codon frequencies in single-stranded RNA viruses. J. Gen. Virol. 1997, 78, 2859-2870. [CrossRef] [PubMed]
42. El Mubarak, H.S., van de Bildt, M.W.G., Mustafa, O.A., Vos, H.W., Mukhtar, M.M., Ibrahim, S.A., Andeweg, A.C., El Hassan, A.M., Osterhaus, A.D.M.E., de Swart, R.L. Genetic characterization of wild-type measles viruses circulating in suburban Khartoum, 1997-2000. J. Gen. Virol. 2002, 83, 1437-1443. [CrossRef] [PubMed]
43. Jenkins, G.M., Rambaut, A., Pybus, O.G., Holmes, E.C. Rates of molecular evolution in RNA viruses: A quantitative phylogenetic analysis. J. Mol. Evol. 2002, 54, 156-165. [CrossRef] [PubMed]
44. Gojobori, T., Moriyama, E.N., Kimura, M. Molecular clock of viral evolution, and the neutral theory. Proc. Natl. Acad. Sci. USA 1990, 87, 10015-10018. [CrossRef] [PubMed]
45. Leitner, T., Albert, J. The molecular clock of HIV-1 unveiled through analysis of a known transmission history. Proc. Natl. Acad. Sci. USA 1999, 96, 10752-10757. [CrossRef] [PubMed]
46. Gorman, O.T., Bean, W.J., Kawaoka, Y., Webster, R.G. Evolution of the nucleoprotein gene of influenza A virus. J. Virol. 1990, 64, 1487-1497. [PubMed]
47. Martínez, M.A., Dopazo, J., Hernández, J., Mateu, M.G., Sobrino, F., Domingo, E., Knowles, N.J. Evolution of the capsid protein genes of foot-and-mouth disease virus: Antigenic variation without accumulation of amino acid substitutions over six decades. J. Virol. 1992, 66, 3557-3565. [PubMed]
48. Rima, B.K., Earle, J.A., Baczko, K., ter Meulen, V., Liebert, U.G., Carstens, C., Carabaña, J., Caballero, M., Celma, M.L., Fernandez-Muñoz, R. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 1997, 78 Pt 1, 97-106. [CrossRef] [PubMed]
49. Furuse, Y., Suzuki, A., Oshitani, H. Origin of measles virus: Divergence from rinderpest virus between the 11th and 12th centuries. Virol. J. 2010, 7. [CrossRef] [PubMed]
50. Pomeroy, L.W., Bjørnstad, O.N., Holmes, E.C. The evolutionary and epidemiological dynamics of the paramyxoviridae. J. Mol. Evol. 2008, 66, 98-106. [CrossRef] [PubMed]
51. Kimura, H., Saitoh, M., Kobayashi, M., Ishii, H., Saraya, T., Kurai, D., Tsukagoshi, H., Shirabe, K., Nishina, A., Kozawa, K., et al. Molecular evolution of haemagglutinin (H) gene in measles virus. Sci. Rep. 2015, 5, 11648. [CrossRef] [PubMed]
52. Monne, I., Fusaro, A., Valastro, V., Citterio, C., Pozza, M.D., Obber, F., Trevisiol, K., Cova, M., De Benedictis, P., Bregoli, M., et al. A distinct CDV genotype causing a major epidemic in Alpine wildlife. Vet. Microbiol. 2011, 150, 63-69. [CrossRef] [PubMed]
53. Padhi, A., Ma, L. Genetic and epidemiological insights into the emergence of peste des petits ruminants virus (PPRV) across Asia and Africa. Sci. Rep. 2014, 4, 7040. [CrossRef] [PubMed]
54. Miller, P.J., Kim, L.M., Ip, H.S., Afonso, C.L. Evolutionary dynamics of Newcastle disease virus. Virology 2009, 391, 64-72. [CrossRef] [PubMed]
55. Ramey, A.M., Reeves, A.B., Ogawa, H., Ip, H.S., Imai, K., Bui, V.N., Yamaguchi, E., Silko, N.Y., Afonso, C.L. Genetic diversity and mutation of avian paramyxovirus serotype 1 (Newcastle disease virus) in wild birds and evidence for intercontinental spread. Arch. Virol. 2013, 158, 2495-2503. [CrossRef] [PubMed]
56. Chong, Y.L., Padhi, A., Hudson, P.J., Poss, M. The effect of vaccination on the evolution and population dynamics of avian paramyxovirus-1. PLoS Pathog. 2010, 6, e1000872. [CrossRef] [PubMed]
57. Beck, E.T., He, J., Nelson, M.I., Bose, M.E., Fan, J., Kumar, S., Henrickson, K.J. Genome sequencing and phylogenetic analysis of 39 human parainfluenza virus type 1 strains isolated from 1997-2010. PLoS ONE 2012, 7, e46048. [CrossRef] [PubMed]
58. Mizuta, K., Saitoh, M., Kobayashi, M., Tsukagoshi, H., Aoki, Y., Ikeda, T., Abiko, C., Katsushima, N., Itagaki, T., Noda, M., et al. Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan. Virol. J. 2011, 8. [CrossRef] [PubMed]
59. Kiptinness, J.K., Wurapa, E.K., Wamunyokoli, F., Bulimo, W.D. Molecular characterization of human parainfluenza virus type 1 in infants attending Mbagathi District Hospital, Nairobi, Kenya: A retrospective study. Virus Genes 2013, 47, 439-447. [CrossRef] [PubMed]
60. Mizuta, K., Tsukagoshi, H., Ikeda, T., Aoki, Y., Abiko, C., Itagaki, T., Nagano, M., Noda, M., Kimura, H. Molecular evolution of the haemagglutinin-neuraminidase gene in human parainfluenza virus type 3 isolates from children with acute respiratory illness in Yamagata prefecture, Japan. J. Med. Microbiol. 2014, 63, 570-577. [CrossRef] [PubMed]
61. Rahman, S.A., Hassan, S.S., Olival, K.J., Mohamed, M., Chang, L.Y., Hassan, L., Saad, N.M., Shohaimi, S.A., Mamat, Z.C., Naim, M.S., et al. Characterization of Nipah virus from naturally infected Pteropus vampyrus bats, Malaysia. Emerg. Infect. Dis. 2010, 16, 1990-1993. [CrossRef] [PubMed]
62. Yang, C.-F., Wang, C.K., Tollefson, S.J., Piyaratna, R., Lintao, L.D., Chu, M., Liem, A., Mark, M., Spaete, R.R., Crowe, J.E., et al. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol. J. 2009, 6. [CrossRef] [PubMed]
63. De Graaf, M., Osterhaus, A.D.M.E., Fouchier, R.A.M., Holmes, E.C. Evolutionary dynamics of human and avian metapneumoviruses. J. Gen. Virol. 2008, 89, 2933-2942. [CrossRef] [PubMed]
64. Padhi, A., Verghese, B. Positive natural selection in the evolution of human metapneumovirus attachment glycoprotein. Virus Res. 2008, 131, 121-131. [CrossRef] [PubMed]
65. Tan, L., Coenjaerts, F.E.J., Houspie, L., Viveen, M.C., van Bleek, G.M., Wiertz, E.J.H.J., Martin, D.P., Lemey, P. The comparative genomics of human respiratory syncytial virus subgroups A and B: Genetic variability and molecular evolutionary dynamics. J. Virol. 2013, 87, 8213-8226. [CrossRef] [PubMed]
66. Zlateva, K.T., Lemey, P., Vandamme, A., Van Ranst, M. Molecular Evolution and Circulation Patterns of Human Respiratory Syncytial Virus Subgroup A: Positively Selected Sites in the Attachment G Glycoprotein Molecular Evolution and Circulation Patterns of Human Respiratory Syncytial Virus Subgroup A: Positi. J. Virol. 2004, 78, 4675-4683. [CrossRef] [PubMed]
67. Yoshida, A., Kiyota, N., Kobayashi, M., Nishimura, K., Tsutsui, R., Tsukagoshi, H., Hirano, E., Yamamoto, N., Ryo, A., Saitoh, M., et al. Molecular epidemiology of the attachment glycoprotein (G) gene in respiratory syncytial virus in children with acute respiratory infection in Japan in 2009/2010. J. Med. Microbiol. 2012, 61, 820-829. [CrossRef] [PubMed]
68. Matheson, J.W., Rich, F.J., Cohet, C., Grimwood, K., Huang, Q.S., Penny, D., Hendy, M.D., Kirman, J.R., Bobek, V., Kolostova, K., et al. Distinct Patterns of Evolution Between Respiratory Syncytial Virus Subgroups A and B From New Zealand Isolates Collected Over Thirty-Seven Years. Anticancer Res. 2006, 30, 4799-4804. [CrossRef] [PubMed]
69. Tsukagoshi, H., Yokoi, H., Kobayashi, M., Kushibuchi, I., Okamoto-Nakagawa, R., Yoshida, A., Morita, Y., Noda, M., Yamamoto, N., Sugai, K., et al. Genetic analysis of attachment glycoprotein (G) gene in new genotype ON1 of human respiratory syncytial virus detected in Japan. Microbiol. Immunol. 2013, 57, 655-659. [CrossRef] [PubMed]
70. Kushibuchi, I., Kobayashi, M., Kusaka, T., Tsukagoshi, H., Ryo, A., Yoshida, A., Ishii, H., Saraya, T., Kurai, D., Yamamoto, N., et al. Molecular evolution of attachment glycoprotein (G) gene in human respiratory syncytial virus detected in Japan 2008-2011. Infect. Genet. Evol. 2013, 18, 168-173. [CrossRef] [PubMed]
71. Pretorius, M.A., Van Niekerk, S., Tempia, S., Moyes, J., Cohen, C., Madhi, S.A., Venter, M. Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J. Infect. Dis. 2013, 208, S227-S237. [CrossRef] [PubMed]
72. Malasao, R., Okamoto, M., Chaimongkol, N., Imamura, T., Tohma, K., Dapat, I., Dapat, C., Suzuki, A., Saito, M., Saito, M., et al. Molecular characterization of human respiratory syncytial virus in the Philippines, 2012-2013. PLoS ONE 2015, 10. [CrossRef] [PubMed]
73. Trento, A., Viegas, M., Galiano, M., Carballal, G., Mistchenko, A.S., Melero, A., Videla, C. Natural History of Human Respiratory Syncytial Virus Inferred from Phylogenetic Analysis of the Attachment (G) Glycoprotein with a 60-Nucleotide Duplication. J. Viol. 2006, 80, 975-984. [CrossRef] [PubMed]
74. Buonagurio Nakada, S., PArvin, J.D., Krystal, M., Palese, P., Fitch, W.M.D.A. Evolution of human influenza A viruses over 50 years: Rapid, uniform rate of change in NS gene. Science 1986, 232, 980-982. [CrossRef]
75. Hanada, K., Suzuki, Y., Gojobori, T. A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol. Biol. Evol. 2004, 21, 1074-1080. [CrossRef] [PubMed]
76. Rima, B.K., Duprex, W.P. Molecular mechanisms of measles virus persistence. Virus Res. 2005, 111, 132-147. [CrossRef] [PubMed]
77. Rima, B.K., Gatherer, D., Young, D.F., Norsted, H., Randall, R.E., Davison, A.J. Stability of the Parainfluenza Virus 5 Genome Revealed by Deep Sequencing of Strains Isolated from Different Hosts and following Passage in Cell Culture. J. Virol. 2014, 88, 3826-3836. [CrossRef] [PubMed]
78. Jin, L., Örvell, C., Myers, R., Rota, P.A., Nakayama, T., Forcic, D., Hiebert, J., Brown, K.E. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev. Med. Virol. 2015, 25, 85-101. [CrossRef] [PubMed]
79. Cui, A., Brown, D.W.G., Xu, W., Jin, L. Genetic Variation in the HN and SH Genes of Mumps Viruses: A Comparison of Strains from Mumps Cases with and without Neurological Symptoms. PLoS ONE 2013, 8, e61791. [CrossRef] [PubMed]
80. Halpin, K., Young, P.L., Field, H.E., Mackenzie, J.S. Isolation of Hendra virus from pteropid bats: A natural reservoir of Hendra virus. J. Gen. Virol. 2000, 81, 1927-1932. [CrossRef] [PubMed]
81. AbuBakar, S., Chang, L.-Y., Ali, A.R.M., Sharifah, S.H., Yusoff, K., Zamrod, Z. Isolation and molecular identification of Nipah virus from pigs. Emerg. Infect. Dis. 2004, 10, 2228-2230. [CrossRef] [PubMed]
82. Chua, K.B., Lek Koh, C., Hooi, P.S., Wee, K.F., Khong, J.H., Chua, B.H., Chan, Y.P., Lim, M.E., Lam, S.K. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 2002, 4, 145-151. [CrossRef]
83. Drake, J.W., Holland, J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 1999, 96, 13910-13913. [CrossRef] [PubMed]
84. Holland, J.J., De La Torre, J.C., Steinhauer, D.A. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 1992, 176, 1-20. [PubMed]
85. Cattaneo, R., Billeter, M.A. Genetic Diversity of RNA Viruses; Holland, J.J., Ed., Current Topics in Microbiology and Immunology; Springer: Berlin, Germany; Heidelberg, Germany, 1992; Volume 176.
86. Zhang, X., Rennick, L.J., Duprex, W.P., Rima, B.K. Determination of spontaneous mutation frequencies in measles virus under nonselective conditions. J. Virol. 2013, 87, 2686-2692. [CrossRef] [PubMed]
87. Schrag, S.J., Rota, P.A., Bellini, W.J. Spontaneous mutation rate of measles virus: Direct estimation based on mutations conferring monoclonal antibody resistance. J. Virol. 1999, 73, 51-54. [PubMed]
88. Hughes, A.L., Hughes, M.A.K. More effective purifying selection on RNA viruses than in DNA viruses. Gene 2007, 404, 117-125. [CrossRef] [PubMed]
89. Kolakofsky, D., Pelet, T., Garcin, D., Hausmann, S., Curran, J., Roux, L. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: The rule of six revisited. J. Virol. 1998, 72, 891-899. [PubMed]
90. Bankamp, B., Liu, C., Rivailler, P., Bera, J., Shrivastava, S., Kirkness, E.F., Bellini, W.J., Rota, P.A. Wild-type measles viruses with non-standard genome lengths. PLoS ONE 2014, 9, e95470. [CrossRef] [PubMed]
91. Cordey, S., Roux, L. Further characterization of a paramyxovirus transcription initiation signal: Search for required nucleotides upstream and importance of the N phase context. J. Gen. Virol. 2007, 88, 1555-1564. [CrossRef] [PubMed]
92. Lai, M.M. RNA recombination in animal and plant viruses. Microbiol. Rev. 1992, 56, 61-79. [PubMed]
93. Han, G.Z., Worobey, M. Homologous recombination in negative sense RNA viruses. Viruses 2011, 3, 1358-1373. [CrossRef] [PubMed]
94. Schierup, M.H., Mordhorst, C.H., Muller, C.P., Christensen, L.S. Evidence of recombination among early-vaccination era measles virus strains. BMC Evol. Biol. 2005, 5. [CrossRef] [PubMed]
95. Chare, E.R., Gould, E.A., Holmes, E.C. Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses. J. Gen. Virol. 2003, 84, 2691-2703. [CrossRef] [PubMed]
96. Li, M., Kao, E., Gao, X., Sandig, H., Limmer, K., Pavon-Eternod, M., Jones, T.E., Landry, S., Pan, T., Weitzman, M.D., et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 2012, 491, 125-128. [CrossRef] [PubMed]
97. Rima, B.K. Nucleotide sequence conservation in paramyxoviruses; the concept of codon constellation. J. Gen. Virol. 2015, 96, 939-955. [CrossRef] [PubMed]
98. Bass, B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71, 817-846. [CrossRef] [PubMed]
99. Woelk, C.H., Jin, L., Holmes, E.C., Brown, D.W. Immune and artificial selection in the haemagglutinin (H) glycoprotein of measles virus. J. Gen. Virol. 2001, 82, 2463-2474. [CrossRef] [PubMed]
100. Cattaneo, R., Schmid, A., Rebmann, G., Baczko, K., ter Meulen, V., Bellini, W.J., Rozenblatt, S., Billeter, M.A. Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: Interrupted matrix protein reading frame and transcription alteration. Virology 1986, 154, 97-107. [CrossRef]
101. Li, Z., Okonski, K.M., Samuel, C.E. Adenosine Deaminase Acting on RNA 1 (ADAR1) Suppresses the Induction of Interferon by Measles Virus. J. Virol. 2012, 86, 3787-3794. [CrossRef] [PubMed]
102. Toth, A.M., Li, Z., Cattaneo, R., Samuel, C.E. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J. Biol. Chem. 2009, 284, 29350-29356. [CrossRef] [PubMed]
103. Chambers, P., Rima, B.K., Duprex, W.P. Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J. Gen. Virol. 2009, 90, 2973-2981. [CrossRef] [PubMed]
104. Martínez, I., Dopazo, J., Melero, J.A. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J. Gen. Virol. 1997, 78, 2419-2429. [CrossRef] [PubMed]
105. Seki, F., Yamada, K., Nakatsu, Y., Okamura, K., Yanagi, Y., Nakayama, T., Komase, K., Takeda, M. The SI Strain of Measles Virus Derived from a Patient with Subacute Sclerosing Panencephalitis Possesses Typical Genome Alterations and Unique Amino Acid Changes That Modulate Receptor Specificity and Reduce Membrane Fusion Activity. J. Virol. 2011, 85, 11871-11882. [CrossRef] [PubMed]
106. Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., ter Meulen, V., Billeter, M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988, 55, 255-265. [CrossRef]
107. Baczko, K., Lampe, J., Liebert, U.G., Brinckmann, U., ter Meulen, V., Pardowitz, I., Budka, H., Cosby, S.L., Isserte, S., Rima, B.K. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 1993, 197, 188-195. [CrossRef] [PubMed]
108. Wong, T.C., Ayata, M., Ueda, S., Hirano, A. Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J. Virol. 1991, 65, 2191-2199. [PubMed]
109. Ahmad, S.B., Tan, C.T. Nipah encephalitis—An update. Med. J. Malays. 2014, 69, 103-111.
110. Abdullah, S., Chang, L.Y., Rahmat, K., Goh, K.J., Tan, C.T. Late-onset Nipah virus encephalitis 11 years after the initial outbreak: A case report. Neurol. Asia 2012, 17, 71-74.
111. Shu, Y., Habchi, J., Costanzo, S., Padilla, A., Brunel, J., Gerlier, D., Oglesbee, M., Longhi, S. Plasticity in structural and functional interactions between the phosphoprotein and nucleoprotein of measles virus. J. Biol. Chem. 2012, 287, 11951-11967. [CrossRef] [PubMed]
112. Longhi, S., Receveur-Bréchot, V., Karlin, D., Johansson, K., Darbon, H., Bhella, D., Yeo, R., Finet, S., Canard, B. The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. J. Biol. Chem. 2003, 278, 18638-18648. [CrossRef] [PubMed]
113. Jensen, M.R., Communie, G., Ribeiro, E.A., Martinez, N., Desfosses, A., Salmon, L., Mollica, L., Gabel, F., Jamin, M., Longhi, S., et al. Intrinsic disorder in measles virus nucleocapsids. Proc. Natl. Acad. Sci. USA 2011, 108, 9839-9844. [CrossRef] [PubMed]
114. Karlin, D., Ferron, F., Canard, B., Longhi, S. Structural disorder and modular organization in Paramyxovirinae N and P. J. Gen. Virol. 2003, 84, 3239-3252. [CrossRef] [PubMed]
115. Bourhis, J.M., Canard, B., Longhi, S. Structural disorder within the replicative complex of measles virus: Functional implications. Virology 2006, 344, 94-110. [CrossRef] [PubMed]
116. Bankamp, B., Takeda, M., Zhang, Y., Xu, W., Rota, P.A. Genetic characterization of measles vaccine strains. J. Infect. Dis. 2011, 204, 533-548. [CrossRef] [PubMed]
117. Bankamp, B., Lopareva, E.N., Kremer, J.R., Tian, Y., Clemens, M.S., Patel, R., Fowlkes, A.L., Kessler, J.R., Muller, C.P., Bellini, W.J., et al. Genetic variability and mRNA editing frequencies of the phosphoprotein genes of wild-type measles viruses. Virus Res. 2008, 135, 298-306. [CrossRef] [PubMed]
118. Baczko, K., Pardowitz, I., Rima, B.K., ter Meulen, V. Constant and variable regions of measles virus proteins encoded by the nucleocapsid and phosphoprotein genes derived from lytic and persistent viruses. Virology 1992, 190, 469-474. [CrossRef]
119. Bankamp, B., Fontana, J.M., Bellini, W.J., Rota, P.A. Adaptation to cell culture induces functional differences in measles virus proteins. Virol. J. 2008, 5. [CrossRef] [PubMed]
120. Takeda, M., Kato, A., Kobune, F., Sakata, H., Li, Y., Shioda, T., Sakai, Y., Asakawa, M., Nagai, Y. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 1998, 72, 8690-8696. [PubMed]
121. Takeda, M., Sakaguchi, T., Li, Y., Kobune, F., Kato, A., Nagai, Y. The genome nucleotide sequence of a contemporary wild strain of measles virus and its comparison with the classical Edmonston strain genome. Virology 1999, 256, 340-350. [CrossRef] [PubMed]
122. Devaux, P., Cattaneo, R. Measles Virus Phosphoprotein Gene Products: Conformational Flexibility of the P/V Protein Amino-Terminal Domain and C Protein Infectivity Factor Function Measles Virus Phosphoprotein Gene Products: Conformational Flexibility of the P/V Protein Amino. J. Virol. 2004, 78, 11632-11640. [CrossRef] [PubMed]
123. Rahaman, A., Srinivasan, N., Shamala, N., Shaila, M.S., Castagne, N., Barbier, A., Bernard, J., Rezaei, H., Huet, J.-C., Henry, C., et al. Paramyxovirus Phosphoproteins Form Homotrimers as Determined by an Epitope Dilution Assay, via Predicted Coiled Coils. Virology 2004, 279, 23606-23614.
124. Gely, S., Lowry, D.F., Bernard, C., Jensen, M.R., Blackledge, M., Costanzo, S., Bourhis, J.M., Darbon, H., Daughdrill, G., Longhi, S. Solution structure of the C-terminal X domain of the measles virus phosphoprotein and interaction with the intrinsically disordered C-terminal domain of the nucleoprotein. J. Mol. Recognit. 2010, 23, 435-447. [CrossRef] [PubMed]
125. Melin, L., Persson, R., Andersson, A., Bergstrm, A., Rnnholrn, R., Pettersson, R.F. Protein interactions entered into by the measles virus P, V, and C proteins. Virus Res. 1995, 36, 49-66. [CrossRef]
126. Lo, M.K., Søgaard, T.M., Karlin, D.G. Evolution and structural organization of the C proteins of paramyxovirinae. PLoS ONE 2014, 9, e90003. [CrossRef] [PubMed]
127. Kai, C., Yamanouchi, K., Sakata, H., Miyashita, N., Takahashi, H., Fumio, K. Nucleotide Sequences of the M Gene of Prevailing Wild Measles Viruses and a Comparison with Subacute Sclerosing Panencephalitis Virus. Virus Genes 1996, 12, 85-87. [CrossRef] [PubMed]
128. Seal, B.S. Analysis of matrix protein gene nucleotide sequence diversity among Newcastle disease virus isolates demonstrates that recent disease outbreaks are caused by viruses of psittacine origin. Virus Genes 1995, 11, 217-224. [CrossRef] [PubMed]
129. Afzal, M.A., Pickford, A.R., Yates, P.J., Forsey, T., Minor, P.D. Matrix protein gene sequence of vaccine andvaccine-associated strains of mumps virus. J. Gen. Virol. 1994, 75, 1169-1172. [CrossRef] [PubMed]
130. Cathomen, T., Mrkic, B., Spehner, D., Drillien, R., Naef, R., Pavlovic, J., Aguzzi, A., Billeter, M.A., Cattaneo, R. A matrix-less measles virus is infectious and elicits extensive cell fusion: Consequences for propagation in the brain. EMBO J. 1998, 17, 3899-3908. [CrossRef] [PubMed]
131. Takeuchi, K., Miyajima, N., Kobune, F., Tashiro, M. Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and Vero cell-isolated measles viruses from the same patient. Virus Genes 2000, 20, 253-257. [CrossRef] [PubMed]
132. Kweder, H., Ainouze, M., Cosby, S.L., Muller, C.P., Lévy, C., Verhoeyen, E., Cosset, F.L., Manet, E., Buckland, R. Mutations in the H, F, or M proteins can facilitate resistance of measles virus to neutralizing human anti-MV sera. Adv. Virol. 2014, 2014, 205617. [CrossRef] [PubMed]
133. Bellini, W.J., Rota, P.A. Genetic diversity of wild-type measles viruses: Implications for global measles elimination programs. Emerg. Infect. Dis. 1998, 4, 29-35. [CrossRef] [PubMed]
134. Santiago, C., Celma, M.L., Stehle, T., Casasnovas, J.M. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat. Struct. Mol. Biol. 2010, 17, 124-129. [CrossRef] [PubMed]
135. Tatsuo, H., Ono, N., Tanaka, K., Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406, 893-897. [PubMed]
136. Mühlebach, M.D., Mateo, M., Sinn, P.L., Prüfer, S., Uhlig, K.M., Leonard, V.H.J., Navaratnarajah, C.K., Frenzke, M., Wong, X.X., Sawatsky, B., et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011, 480, 530-533. [CrossRef] [PubMed]
137. Naniche, D., Varior-krishnan, G., Cervoni, F., Wild, T.F., Rossi, B., Rabourdin-combe, C., Gerlierl, D. Human Membrane Cofactor Protein (CD46) Acts as a Cellular Receptor for Measles Virus. J. Virol. 1993, 67, 6025-6032. [PubMed]
138. Buchholz, C.J., Koller, D., Devaux, P., Mumenthaler, C., Schneider-Schaulies, J., Braun, W., Gerlier, D., Cattaneo, R. Mapping of the primary binding sites of measles virus to its receptor CD46. J. Biol. Chem. 1997, 272, 22072-22079. [CrossRef] [PubMed]
139. Noyce, R.S., Bondre, D.G., Ha, M.N., Lin, L.T., Sisson, G., Tsao, M.S., Richardson, C.D. Tumor cell marker pvrl4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011, 7, e1002240. [CrossRef] [PubMed]
140. Schneider, U., Von Messling, V., Devaux, P., Cattaneo, R. Efficiency of Measles Virus Entry and Dissemination through Different Receptors Efficiency of Measles Virus Entry and Dissemination through Different Receptors. Society 2002, 76, 7460-7467.
141. Santiago, C., Björling, E., Stehle, T., Casasnovas, J.M. Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. J. Biol. Chem. 2002, 277, 32294-32301. [CrossRef] [PubMed]
142. Leonard, V.H.J., Sinn, P.L., Hodge, G., Miest, T., Devaux, P., Oezguen, N., Braun, W., McCray, P.B., McChesney, M.B., Cattaneo, R. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Investig. 2008, 118, 2448-2458. [CrossRef] [PubMed]
143. Tahara, M., Takeda, M., Shirogane, Y., Hashiguchi, T., Ohno, S., Yanagi, Y. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J. Virol. 2008, 82, 4630-4637. [CrossRef] [PubMed]
144. Leonard, V.H.J., Hodge, G., Reyes-Del Valle, J., McChesney, M.B., Cattaneo, R. Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys. J. Virol. 2010, 84, 3413-3420. [CrossRef] [PubMed]
145. Zhang, X., Lu, G., Qi, J., Li, Y., He, Y., Xu, X., Shi, J., Zhang, C.W.-H., Yan, J., Gao, G.F. Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4. Nat. Struct. Mol. Biol. 2013, 20, 67-72. [CrossRef] [PubMed]
146. Chatziandreou, N., Stock, N., Young, D., Andrejeva, J., Hagmaier, K., McGeoch, D.J., Randall, R.E. Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J. Gen. Virol. 2004, 85, 3007-3016. [CrossRef] [PubMed]
147. Bose, S., Jardetzky, T.S., Lamb, R.A. Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry. Virology 2015, 479-480, 518-531. [CrossRef] [PubMed]
148. Plattet, P., Plemper, R.K. Envelope protein dynamics in paramyxovirus entry. MBio 2013, 4, 16. [CrossRef] [PubMed]
149. Dochow, M., Krumm, S.A., Crowe, J.E., Moore, M.L., Plemper, R.K. Independent structural domains in Paramyxovirus polymerase protein. J. Biol. Chem. 2012, 287, 6878-6891. [CrossRef] [PubMed]
150. Parks, C.L., Lerch, R.A.; Walpita, P.; Wang, H.P., Sidhu, M.S., Udem, S.A. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J. Virol. 2001, 75, 910-920. [CrossRef] [PubMed]
151. Wise, M.G., Sellers, H.S., Alvarez, R., Seal, B.S. RNA-dependent RNA polymerase gene analysis of worldwide Newcastle disease virus isolates representing different virulence types and their phylogenetic relationship with other members of the paramyxoviridae. Virus Res. 2004, 104, 71-80. [CrossRef] [PubMed]
152. Horikami, S.M., Smallwood, S., Bankamp, B., Moyer, S.A. An amino-proximal domain of the L protein binds to the P protein in the measles virus RNA polymerase complex. Virology 1994, 205, 540-545. [CrossRef] [PubMed]
153. Sidhu, M.S., Menonna, J.P., Cook, S.D., Dowling, P.C., Udem, S.A. Canine distemper virus L gene: Sequence and comparison with related viruses. Virology 1993, 193, 50-65. [CrossRef] [PubMed]
154. Hu, K., Lin, C.; Wang, X. [Nucleotide sequence of the noncoding regions of measles virus stain CC-47 and comparison with other measles viruses]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2001, 15, 327-331. [PubMed]
155. Parks, C.L., Lerch, R.A., Walpita, P., Wang, H., Sidhu, M.S., Udem, S.A. Analysis of the Noncoding Regions of Measles Virus Strains in the Edmonston Vaccine Lineage. Society 2001, 75, 921-933. [CrossRef] [PubMed]
156. Bankamp, B., Hodge, G., McChesney, M.B., Bellini, W.J., Rota, P.A. Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 2008, 373, 39-50. [CrossRef] [PubMed]
157. Liu, X., Bankamp, B., Xu, W., Bellini, W.J., Rota, P.A. The genomic termini of wild-type and vaccine strains of measles virus. Virus Res. 2006, 122, 78-84. [CrossRef] [PubMed]
158. Skiadopoulos, M.H., Surman, S., Tatem, J.M., Paschalis, M., Wu, S.L., Udem, S.A., Durbin, A.P., Collins, P.L., Murphy, B.R. Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine. J. Virol. 1999, 73, 1374-1381. [PubMed]
159. Kim, S.-H., Samal, S.K. Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein. J. Virol. 2010, 84, 2629-2634. [CrossRef] [PubMed]
160. Rennick, L.J., Duprex, W.P., Rima, B.K. Measles virus minigenomes encoding two autofluorescent prot einsreveal cell-to-cell variation in reporter expression dependent on viral sequences between the transcription units. J. Gen. Virol. 2007, 88, 2710-2718. [CrossRef] [PubMed]
161. Edworthy, N.L., Easton, A.J. Mutational analysis of the avian pneumovirus conserved transcriptional gene start sequence identifying critical residues. J. Gen. Virol. 2005, 86, 3343-3347. [CrossRef] [PubMed]
162. Anderson, D.E., von Messling V. Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expression. J. Virol. 2008, 82, 10510-10518. [CrossRef] [PubMed]
163. Takeda, M., Ohno, S., Seki, F., Nakatsu, Y., Tahara, M., Yanagi, Y. Long untranslated regions of the measles virusMand F genes control virus replication and cytopathogenicity. J. Virol. 2005, 79, 14346-14354. [CrossRef] [PubMed]
164. Sinitsyna, O.A., Khudaverdyan, O.E., Steinberg, L.L., Nagieva, F.G., Lotte, V.D., Dorofeeva, L.V., Rozina, E.E., Boriskin, Y.S. Further-attenuated measles vaccine: Virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo. Res. Virol. 1990, 141, 517-531. [CrossRef]
165. Valsamakis, A., Schneider, H., Auwaerter, P.G., Kaneshima, H., Billeter, M.A., Griffin, D.E. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 1998, 72, 7754-7761. [PubMed]
166. Heider, A., Santibanez, S., Tischer, A., Gerike, E., Tikhonova, N., Ignatyev, G., Mrazova, M., Enders, G., Schreier, E. Comparative investigation of the long non-coding M-F genome region of wild-type and vaccine measles viruses. Arch. Virol. 1997, 142, 2521-2528. [CrossRef] [PubMed]
167. Baricevic, M., Forcic, D., Santak, M., Mazuran, R. A comparison of complete untranslated regions of measles virus genomes derived from wild-type viruses and SSPE brain tissues. Virus Genes 2007, 35, 17-27. [CrossRef] [PubMed]